Skin Diseases Completed Phase 3 Trials for Dupilumab (DB12159)

Also known as: Skin Disease / Iatrogenic dermatosis / Disease of skin (disorder) / Skin disorder / Dermatosis / Skin disorder NOS

IndicationStatusPhase
DBCOND0028161 (Skin Diseases)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03720470Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical TherapyTreatment